Long-term results of ethanol embolization of renal cell carcinoma.
This retrospective study was conducted to evaluate the long-term results of transarterial embolization with absolute ethanol (ethanol-TAE) for patients with renal cell carcinoma (RCC). Twenty-eight patients, including 15 stage IVb patients, underwent ethanol-TAE, with 12 of them followed by nephrectomy. The cumulative survival rates after 1, 3, and 5 years were 71%, 54%, and 54% in the surgical group, and 54%, 33%, and 22% in the non-surgical group. From the results, we recommend ethanol-TAE for advanced stage patients for the following reasons: first, it can be a useful alternative to nephrectomy in high-risk patients; second, ethanol-TAE can decrease the primary tumor size increasing operability; and third, local tumor control may result in longer survival.
Saitoh
H
H
Department of Radiology, Kyoto City Hospital, Japan.
Hayakawa
K
K
Nishimura
K
K
Kubo
S
S
Hida
S
S
D000368:Aged; D000369:Aged, 80 and over; D002292:Carcinoma, Renal Cell / Q000401:mortality / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate
D000431:Ethanol